A detailed history of Evergreen Capital Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 14,471 shares of OGN stock, worth $108,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,471
Previous 11,659 24.12%
Holding current value
$108,966
Previous $112,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$8.4 - $10.85 $23,620 - $30,510
2,812 Added 24.12%
14,471 $154,000
Q2 2025

Aug 14, 2025

SELL
$8.04 - $14.72 $94,871 - $173,696
-11,800 Reduced 50.3%
11,659 $112,000
Q1 2025

May 15, 2025

SELL
$14.29 - $16.41 $20,677 - $23,745
-1,447 Reduced 5.81%
23,459 $349,000
Q4 2024

Feb 13, 2025

SELL
$14.44 - $18.83 $82,596 - $107,707
-5,720 Reduced 18.68%
24,906 $371,000
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $3,804 - $4,698
-204 Reduced 0.66%
30,626 $585,000
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $20,748 - $26,110
1,189 Added 4.01%
30,830 $638,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $68,996 - $94,131
5,007 Added 20.33%
29,641 $557,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $269,742 - $426,660
24,634 New
24,634 $355,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $12,948 - $15,910
-409 Reduced 5.59%
6,907 $233,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $10,078 - $13,028
-331 Reduced 4.33%
7,316 $256,000
Q4 2021

Mar 11, 2022

SELL
$28.67 - $37.13 $27,551 - $35,681
-961 Reduced 11.16%
7,647 $233,000
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $38,994 - $48,541
1,362 Added 18.8%
8,608 $282,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $206,148 - $275,348
7,246 New
7,246 $219,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.